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ABSTRACT Globomycin-resistant mutants of Escherichia coli have been isolated and partially characterized.
Approximately 2-5% of these mutants synthesize structurally altered Braun's lipoprotein. The majority of these
mutants contain unprocessed and unmodified prolipoprotein. One mutant is found to contain modified, processed, but
structurally altered lipoprotein. Mutants containing lipid-deficient prolipoprotein or lipoprotein also show increased
resistance to globomycin. These results suggest that the inhibition of processing of modified prolipoprotein by
globomycin may require fully modified prolipoprotein as the biochemical target of this novel antibiotic. Our failure to
isolate mutant containing cleaved but unmodified lipoprotein among globomycin-resistant mutants is consistent with
the possibility that modification of prolipoprotein precedes the removal of signal sequence by a unique signal peptidase.
Recent evidence indicates that the minor lipoproteins in the cell envelope of E. coli are also synthesized as
lipid-containing prolipoproteins and the processing of these prolipoproteins is inhibited by globomycin. These results
suggest the existence of modifying enzymes in E. coli which would transfer glyceryl and fatty acyl moieties to cysteine
residues located in the proper sequences of the precursor proteins. This speculation is confirmed by our demonstration
that Bacillus licheniformis penicillinase synthesized in E. coli as well as in B. licheniformis is a lipoprotein containing
glyceride-cysteine at its NH2-terminus.
INTRODUCTION
The outer membrane of gram-negative bacteria contains
abundant copies of a few proteins, the so-called major
outer membrane proteins. One of the major outer
membrane proteins in Escherichia coli and other gram-
negative bacteria is the murein lipoprotein discovered by
Braun and Rehn (1). The amino terminus of this lipopro-
tein consists of a novel lipoamino acid, N-acyl diglyceride-
cysteine (2).
The primary translation product of lipoprotein m-RNA
is a precursor form of lipoprotein called prolipoprotein
which contains a peptide extension of 20 extra amino acids
at the NH2-terminus (Fig. 1) (3). Recently, a novel
antibiotic, globomycin (Fig. 2), has been shown to inhibit
selectively the processing of prolipoprotein (4). Studies by
Mizushima and his co-workers on the mechanism of action
of globomycin have led to two important observations:
glyceride-containing prolipoprotein accumulates in globo-
mycin-treated cells (5), and multiple, albeit minor, lipo-
protein species are identified in both the inner cytoplasmic
and outer membranes of the E. coli cell envelope (6). The
processing of the lipid-containing precursor forms of these
new lipoproteins is also inhibited by globomycin (6).
In this paper, we shall summarize our current knowl-
edge on the biosynthesis and assembly of lipoproteins in
bacteria. Some recent studies on the isolation and charac-
terization of globomycin-resistant mutants will be
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presented. The implication of these findings on the speci-
ficity of the modification and processing of prolipoprotein
will be discussed.
MATERIALS AND METHODS
Bacterial Strains
The bacterial strains used in the present study include E. coli K- 12 strain
E609; globomycin-resistant mutant strains 3-2 and 6-23 derived from
strain E609; strain JE5506, a lpp+ transductant of strain JE5505; strain
WB956 lysogenic with aX phage containing pen gene from B. lichenifor-
mis; and strain IH 4715 of B. licheniformis which is derived from strain
749C. The relevant genotypes of these strains have been previously
described (7, 9).
Growth Media and Culture Conditions
Media used in the present study include M9 minimal medium and
proteose peptone beef extract (PPBE) broth.
Labeling studies were carried out employing these radioactive precur-
sors: [3Hlpalmitate (sp. act. 23.5 Ci/mmol); [2-3H]glycerol (sp. act. 6.35
Ci/mmol); ['4C]leucine (sp. act. 150 mCi/mmol); [35S]cysteine (sp. act.
866 Ci/mmol); and [35Slmethionine (300 mCi/mmol).
Preparation of Cell Envelope and Isolation
of Labeled Proteins with
Immunoprecipitation
The preparation of the crude cell envelope from E. coli and the extraction
of phospholipids were carried out as described (10). Preparation of the
crude cell envelope from B. licheniformis cells, extraction of phospho-
307
1 5 10 15
MetLysAlaThrLysLeuValLeuGlyAlaVaI I le LeuGlySer
20 1 25 30
ThrLeuLeuAlaGlyCyserSerAsnAlaLysIleAspGlnLeu
1 5 10
35 40 45
SerSerAspValGlnThrLeuAsnAlaLysValAspGlnLeuSer
15 20 25
50 55 60
AsnAspValAsnAlaMetArgSerAspVal Gln AlaAlaLysAsp
30 35 40
65 70 75
Asp AlaAlaArgAlaAsnGln ArgLeuAspAsnMetAlaThrLys
45 50 55
78
TyrArgLys
58
FIGURE I Primary structure of prolipoprotein in E. coli. The bracketed
sequence represents the signal sequence which is removed during the
processing of prolipoprotein to form mature lipoprotein.
lipids, isolation of membrane-bound penicillinase, and immunoprecipita-
tion of labeled penicillinase with rabbit antiserum prepared against
exopenicillinase of B. licheniformis, were carried out as described (9).
Isolation and Characterization of
Globomycin-resistant Mutants
E. coli strain E609 grown in PPBE broth was mutagenized with
nitrosoguanidine. Following phenotypic expressions, the mutagenized
cells were treated with globomycin at a final concentration of 30-50
gg/ml at 300C overnight. Single colonies were isolated and screened for
temperature sensitivity in growth on nutrient agar plates, RNase leaki-
ness and the presence or absence of lipoprotein antigen by the Ouchter-
lony double diffusion test using rabbit antisera against purified lipopro-
tein. Those mutants showing positive lipoprotein antigen and phenotypes
suggestive of structural alteration in lipoprotein (7) were further
analyzed biochemically by SDS polyacrylamide gel electrophoresis of
lipoprotein immunoprecitates labeled with radioactive precursors. SDS
polyacrylamide gel electrophoresis was carried out in the presence or
absence of 2-mercaptoethanol to ascertain whether the mutant lipopro-
tein contained unmodified or extra cysteine residues.
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Other biochemical techniques
Sodium dodecyl sulfate/urea polyacrylamide gel electrophoresis was
carried out as described previously (9, 1 1).
RESULTS
Post Translational Modifications of
Prolipoprotein
The structure of prolipoprotein differs from that of mature
murein lipoprotein in a number of ways. Consequently, a
series of post translational modifications and processing
occurs prior to the translocation of mature free-form
lipoprotein to the outer membrane. These modifications
include (a) the transfer of glycerol from the nonacylated
glycerol moiety of phosphatidylglycerol to the sulfhydryl
group of cysteine in prolipoprotein (12); (b) transacylation
of both saturated and unsaturated fatty acids from phos-
pholipids to the glycerolcysteine in prolipoprotein to give
rise to the ester-linked fatty acids in lipoprotein (13, 14);
(c) the proteolytic cleavage of the signal peptide at the
NH2-terminus of prolipoprotein; and (d) transacylation of
palmitate from phospholipid to the a-NH2 group of
cysteine to N-acylate the NH2-terminus of lipoprotein (13,
14). Finally, part of the mature and modified lipoprotein is
covalently linked to peptidoglycan, presumably by trans-
peptidation.
The order of these modifications and processing reac-
tions can be inferred from the recent work on the effect of
globomycin on the processing of prolipoprotein (Fig. 3). If
the processing of prolipoprotein occurs prior to the attach-
ment of glycerol to the lipoprotein, the prolipoprotein
accumulated in the globomycin-treated cells should be
unmodified. However, if modifications by glyceryl trans-
ferase and transacylase take place before the processing by
signal peptidase, the prolipoprotein found in the globomy-
cin-treated cells would be modified to contain covalently
linked glyceride. The latter possibility was shown to be the
case (6) (Fig. 3 a-e). This observation, together with the
simultaneous accumulation of several other glyceride-
containing precursor forms of lipoproteins in globomycin-
treated cells, strongly suggest that modification reactions
as represented by the sequential transfer of glycerol and
fatty acids to prolipoproteins can occur prior to the
removal of signal peptides.
Lipid-deficient Lipoprotein Mutants Show
Increased Resistance to Globomycin
We have recently shown that globomycin is a hydrophobic
antibiotic which can enter the E. coli cells via the so-called
hydrophobic channels (8). We have further shown that
mutants synthesizing lipid-deficient lipoprotein or prolipo-
protein are more resistant to globomycin than their corre-
sponding wild-type parental strains (Table I). Although
earlier workers have suggested the possibility that globo-
mycin is a substrate analogue of the signal sequence in
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FIGURE 2 Structure of globomycin (4).
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FIGURE 3 Alternative pathways for the post-translational modification
and processing of prolipoprotein in E. coli. The pathway on the right is
consistent with the data. a, glyceryl transferase; b, transacylase; c, signal
peptidase; d, transacylase; and e, transpeptidase or ligase.
prolipoprotein (4), it seems plausible that globomycin may
bind to the diglyceride moiety in prolipoprotein, thereby
interfering with its processing and translocation. Inasmuch
as the new lipoproteins may have signal sequences distinct
from that of Braun's lipoprotein, the common effect of
globomycin on the processing of these prolipoproteins of
diverse primary structures may be attributed to the forma-
tion of prolipoprotein-globomycin complexes. The failure
of glyceride-containing prolipoprotein to be translocated
from the cytoplasmic membrane to the outer membrane
might be responsible for the antibiotic action of globomy-
cin (6). The increased resistance of lipid-deficient prolipo-
protein mutant towards globomycin may be accounted for
by the apparently normal translocation of unmodified
uncleaved mutant prolipoprotein to the outer membrane
(15).
We have isolated globomycin-resistant mutants from
several E. coli K- 12 strains. Approximately 2-5% of the
globomycin resistant mutants contain dimeric forms of
Braun's lipoprotein which could be converted into the
monomeric forms by treatment with 2-mercaptoethanol.
The majority of the lipoprotein-dimer mutants synthesize
unprocessed and unmodified prolipoprotein, with the
apparent molecular weights of these mutant lipoproteins
identical to that of the mipA prolipoprotein previously
reported (16) (see Table I). One of the mutants, strain
TABLE I
GLOBOMYCIN RESISTANCE IN E. COLI MUTANTS
CONTAINING LIPID-DEFICIENT LIPOPROTEIN
S Nature of Relative
mutation sensitivity*
Wild type normal structure None 1
ipo mutant none Deletion >4
1pm mutant cleaved, underacyl- Arg57 - Cys57 3-4
ated lipoprotein
mipA mutant uncleaved, unmod- Gly7- Asp7 2-4
ified
Mutant 3-2 uncleaved, unmod- ? 4-5
ified
Mutant 6-23 cleaved, modified X - Cys 4-5
*Minimal effective concentration was determined by measuring plating
efficiency as well as inhibition of growth in liquid cultures in the presence
of varying concentrations of globomycin.
6-23, synthesizes a modified and processed lipoprotein
which forms dimers due to the presence of an extra
cysteine in lipoprotein (Table I). This is similar but not
identical to the Ipm (Ipp-l) mutant previously reported by
Hirota and his co-workers (17), although the exact loca-
tion for the structural alteration in this new Ipp mutation
remains to be determined. Of the dimer-forming mutants
obtained thus far, we have yet to isolate a mutant which
synthesizes cleaved but unmodified lipoprotein. The exis-
tence of the latter class of lipid-deficient lipoprotein
mutant might be expected if the processing of prolipopro-
tein by a signal peptidase precedes the modification of the
cysteine residue. All mutants thus far isolated which are
defective in the modification of lipoprotein synthesize
uncleaved prolipoprotein; this observation suggests that
the modification of prolipoprotein by glyceryl transferase
and transacylases precedes and may indeed be a prerequi-
site of the processing of prolipoprotein by a unique signal
peptidase specific for glyceride-containing prolipoproteins.
We have previously characterized a novel mutant
altered in the structure of murein lipoprotein. Due to a
single amino acid substitution of aspartic acid for glycine
at the 14th position of the prolipoprotein, all of the
posttranslational modifications of prolipoprotein are
aborted. The amount of murein-bound lipoprotein found in
this mutant is greatly reduced as compared to the wild-
type strain. However, the murein-bound lipoprotein, pres-
ent at 4% of the wild-type level, was found to be fully
modified and processed, normal in size, containing both
glyceride and amide-linked fatty acid (18). This observa-
tion is of considerable interest since it suggests that modifi-
cation of lipoprotein may be required for the assembly of
lipoprotein into the murein sacculi. This is consistent with
the observation that glyceride-containing prolipoprotein is
assembled into the peptidoglycan (19). The finding that
the modified bound form of lipoprotein in the mipA
mutant is processed further suggests that the primary
defect in the assembly of mlpA mutant prolipoprotein into
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the peptidoglycan is the poor efficiency of the mutant
prolipoprotein as the substrate for the glyceryltransferase.
The fraction of mipA mutant-prolipoprotein which is
modified by the covalent attachment of glycerol is subse-
quently cleaved to form mature lipoprotein.
A Common Modification and Processing
System for Structurally Different
Lipoproteins in E. coli.
While Braun's lipoprotein is the most abundant protein
and by far the major lipoprotein in E. coli, evidence is
rapidly accumulating to indicate that the presence of
glyceride-cysteine at the NH2-terminus is not unique for
Braun's lipoprotein. In fact, the number of newly recog-
nized lipoprotein species is rapidly increasing (6, 20).
These lipoproteins share several features in common with
Braun's lipoprotein: they contain covalently linked glycer-
ide, they are synthesized as precursor proteins presumably
containing signal sequences at the NH2-termini, and the
processing of these glyceride-containing prolipoproteins is
inhibited by globomycin (6).
The prevalence of various lipoproteins in E. coli
suggests the modification of a number of structurally
unrelated prolipoproteins by a common set of enzymes.
These lipoproteins vary greatly in size and subcellular
localization, and show no immunological cross-reactivity
with antisera against Braun's lipoprotein or with antisera
against Mizuno's lipoprotein (6). In addition, there is no
extensive nucleotide sequence homology between Braun's
lipoprotein gene and the genes for the new lipoproteins, as
measured by hybridization of 32P-labeled Braun's lipopro-
tein mRNA with restriction enzyme fragments of total E.
coli DNA (21). Consequently, the enzyme(s) responsible
for the post-translational modificaton reactions must
recognize some common feature other than the primary
structures of the mature proteins. It is likely that the
amino acid sequence located in the vicinity of the site of
modification and cleavage of these prolipoproteins consti-
tutes such a common structural feature. This speculation
is supported by the similarity in the NH2-terminal
sequences between Braun's lipoprotein and Mizuno's lipo-
protein (Fig. 4) (6). It is further validated by the demon-
stration that B. licheniformis penicillinase synthesized in
(A) SH
-----Leu-Ala-Gly-Cys-Ser-Ser-Asn-Ala-Lys-Ile-Asp-------
-1 ±1 Braun's Lipoprotein
(B) SH
[-----------Cys-Ser-Ser-Asn-Lys-Asn-Asp-Asp----.---
+ 1
Mizuno's Lipoprotein
FIGURE 4 Amino-terminal sequence of Braun's lipoprotein and Mizu-
no's lipoprotein in E. coli.
E. coli is modified and processed as a glycerolipoprotein
(9).
B. licheniformis Penicillinase Synthesized
in E. coli Contains Covalently Linked
Glyceride-Cysteine.
Penicillinase from B. licheniformis exists in three forms:
the exoenzymes, exo F and exo S, which are secreted into
the culture medium, and the membrane-bound form which
is associated with the cytoplasmic membrane, presumably
via the hydrophobic segment at the NH2-terminus (22).
The structural gene for this enzyme has been cloned and
its DNA sequence determined (23). The NH2-terminal
portion of the penicillinase contains a tetrapeptide, -Leu-
Ala-Gly-Cys-, which is located at the end of the hydro-
phobic segment of the signal sequence of penicillinase
(Fig. 5B). This is precisely the same tetrapeptide
surrounding the site of posttranslational modification and
processing of prolipoprotein in E. coli (Fig. 5A). Thus, the
penicillinase gene from B. licheniformis cloned on a X-
transducing phage offers a unique opportunity to test our
working hypothesis. As shown in Fig. 6, penicillinase of B.
licheniformis synthesized in E. coli contains covalently
linked glyceride and fatty acids. It is not labeled, however,
with [32P]phosphate (data not shown). Penicillinase
doubly labeled with [2-3H]glycerol and [35S]sulfate was
isolated from immunoprecipitate by preparative SDS/
urea gel electrophoresis, oxidized with performic acid, and
hydrolyzed with 6N HCl at 1050C in vacuo for 20 h. A
peak doubly labeled with [2-3H]glycerol and [35S]sulfate
with the same electrophoretic mobility of glycerylcysteine
sulfone isolated from Braun's lipoprotein was detected in
the total acid hydrolysate of oxidized penicillinase (data
not shown). Free [2-3H]glycerol was not found in the
hydrolysate of penicillinase beyond the level expected from
the destruction of glycerylcysteine sulfone during hydroly-
sis. This result indicates that the glyceride moiety in
penicillinase is joined through a thioether linkage to the
sulfhydryl group of cysteine, most likely at the NH2-
terminus of the membrane-bound penicillinase.
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FIGURE 5 The amino acid sequence of the NH2-terminal portion of the
prolipoprotein in E. coli (A) and prepenicillinase in B. licheniformis (B).
The complete peptide extension at the NH2-terminus of the exopenicilli-
nase is 42 amino acids long and the tetrapeptide marked borders the only
hydrophobic section within this region. exo-S and exo-F denote slow and
fast migrating forms of exopenicillinase.
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FIGURE 6 Incorporation of [2-3Hlglycerol and [3H]palmitate into B.
licheniformis penicillinase synthesized in E. col. Cells were labeled with
the radioactive precursors as indicated. Envelope fractions were isolated,
extracted three times with chloroform/methanol (2:1), immunoprecipi-
tated with anti-penicillinase antiserum, solubilized in 10 mM sodium
phosphate buffer (pH 7.1) containing 1% SDS, 1% 2-mercaptoethanol
and 10% glycerol at 700C for 20 min and analyzed by SDS/urea
polyacrylamide gel electrophoresis. A, Immunoprecipitated penicillinase
from [2-3H]glycerol- and ['4Clleucine-labeled E. coli strain WB956(X
pen). B, Immunoprecipitated penicillinase from [3H]palmitate and
[35S]methionine-labeled E. coli strain WB956(X pen). Pen, penicillinase;
cyt c, cytochrome c; dye, pyronin Y.
Membrane-bound Penicillinase of B.
licheniformis Contains Glyceride-cysteine
While earlier reports have suggested the presence of
covalently-linked phosphatidylserine at the NH2-terminus
of membrane-bound penicillinase in B. licheniformis (24),
Simons et al. (22) found no phospholipid covalently
attached to the purified membrane-bound penicillinase
from the same species. Our observation that B. lichenifor-
mis penicillinase synthesized in E. coih is a glyceride-
lipoprotein prompted us to reinvestigate the nature of this
enzyme in B. licheniformis. As shown in Fig. 7, the
membrane-bound penicillinase in B. licheniformis is a
glyceride-lipoprotein since it can be readily labeled with
[3H]palmitate and [2-3H]glycerol. There was no incorpo-
ration of [32Plphosphate into this enzyme (data not
shown). Glycerylcysteine sulfone doubly labeled with [2-
3H]glycerol and [3']cysteine was found in the total acid
hydrolysate of performic acid-oxidized membrane-bound
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FIGURE 7 Incorporation of [3H]palmitate and [2-3H]glycerol into
membrane-bound penicillinase in B. licheniformis. B. licheniformis cells
were labeled with radioactive precursors as indicated. Envelope fractions
were isolated, extracted three times with chloroform/methanol, solubi-
lized, immunoprecipitated with anti-penicillinase anti-serum, and
analyzed as described in the legend to Fig. 10. A, Immunoprecipitated
penicillinase from [3H]palmitate- and [35SImethionine-labeled B. licheni-
formis strain IH4715. B, Immunoprecipitated penicillinase from [2-
3H]glycerol and [35S]cysteine-labeled B. licheniformis strain IH4715.
The [2-3H]glycerol-labeled peak migrating slower than cytochrome c is
most likely related to teichoic acid.
penicillinase of B. licheniformis purified by SDS/urea
preparative gel electrophoreis (data not shown). These
results suggest that glyceride-lipoproteins containing
modified cysteine at their NH2-termini are not restricted
to gram-negative bacteria, as previously assumed.
Effects of Globomycin on the Biosynthesis
of B. licheniformis Penicillinase in E. coli
We have postulated that globomycin may not be a struc-
tural analogue of the signal sequence in prolipoproteins
but instead interferes with the processing of prolipopro-
teins by binding noncovalently to the glyceride moiety in
prolipoproteins. The modification of B. licheniformis peni-
cillinase to a glyceride-lipoprotein in E. coli offers an
opportunity to study the effect of globomycin on the
processing of penicillinase. In contrast to the inhibition of
processing of many different prolipoproteins by globomy-
cin treatment, there appears to be a severe inhibition in the
incorporation of palmitate or [2-'H]glycerol into the
membrane-bound penicillinase in both E. coli and in B.
licheniformis. Similar results have been obtained by
Lampen and his co-workers (25). They have also demon-
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FIGURE 8 Postulated pathway for the biosynthesis, modification and
processing of penicillinase from B. licheniformis.
strated an increased production of the exo-forms of peni-
cillinase in globomycin treated cells (25). These results are
consistent with the postulate that the membrane-bound
penicillinase is not an obligatory intermediate in the
formation and secretion of the exo-forms (Fig. 8). This is
further supported by the work of Davis and his colleagues
(26) demonstrating that there are two independent and
cotranslational processings of prepenicillinase, leading to
the formation of either the exo-forms by proteolytic cleav-
age of unmodified prepenicillinase, or the membrane-
bound form which has been modified by the addition of the
lipid moiety. Alternatively, globomycin may have inhib-
ited the processing of modified prepenicillinase and our
failure to detect an accumulation of glyceride-containing
prepenicillinase in globomycin-treated cells may be due to
enhanced processings of modified precursor to form exo-
forms of penicillinase by the alternative pathway (Fig. 8).
DISCUSSION
In this paper, we have summarized some recent develop-
ments in the biogenesis of lipoproteins in bacteria. The
outer membrane lipoprotein represents not only the most
abundant protein in E. coli, but also one of the most
extensively studied, largely due to the pioneering work of
Braun, Inouye and their co-workers (27, 28). The identifi-
cation of many lipoproteins with similar structures in both
gram-negative and gram-positive bacteria (6, 9, 25, 26)
has provided new impetus to the studies of Braun's lipopro-
tein as a prototype of lipoproteins in general. Moreover,
the discovery of the novel antibiotic globomycin has
provided an important tool in the studies of the biosynthe-
sis and assembly of lipoproteins in bacteria.
It is clear from the work of Smith, et al. (26) that the
modification of prepenicillinase is cotranslational. This
finding is consistent with the suggestion that the modifica-
tion of prolipoprotein by the successive transfer of glycerol
and fatty acids precedes the proteolytic removal of the
leader sequence, and the modified glyceride-cysteine may
in fact constitute a "signal" for cleavage by a unique signal
peptidase. The postulated sequence of events is shown in
Fig. 9. Covalent modification of precursor proteins by the
addition of glyceride prior to the removal of leader
sequence may be especially important for the anchorage of
otherwise hydrophilic proteins to the membrane such as B.
licheniformis penicillinase. It is teleologically attractive to
have proteins anchored to the membrane through the
covalently attached lipid before they could leave the
membrane to the aqueous milieu as a result of the removal
of signal sequence. This anchorage may also be necessi-
tated by the nature of other components of the modifica-
tion reaction (phospholipids, membrane-bound enzymes).
Our data show that the modification enzymes recognize a
limited amino acid sequence near the end of the hydro-
phobic segment of the signal sequence of prolipoproteins.
The overall structures of the mature lipoproteins appear to
be less important. This is understandable in view of the
fact that the modification reaction for penicillinase in B.
licheniformis is cotranslational and presumably takes
place prior to completion of the synthesis of polypeptide
chains (26). The recognition of a restricted peptide
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sequence by the modification enzymes to form lipoproteins
may be analogous to the substrate specificity for glycosyla-
tion of proteins to form glycoproteins (29).
The observation that mutant 6-23 and especially 1pm
mutant are resistant to globomycin raises an interesting
question regarding the timing of various modification
reactions and that of signal peptidase. Mutations within
the mature lipoprotein allow either the proper cleavage of
prolipoprotein in the presence of globomycin, or the trans-
location of altered prolipoprotein to the outer membrane
thereby prevents the accumulation of fully modified and
uncleaved prolipoprotein in the cytoplasmic membrane.
Because the Ipm mutation is known to alter the penulti-
mate amino acid from the COOH-terminus of lipoprotein,
a nearly completed prolipoprotein would have to be
synthesized in order for this particular mutation to exert
its effect against the action of globomycin. This would
suggest that the cleavage of signal sequence in prolipopro-
tein occurs post-translationally. Lpm mutant lipoprotein
also lacks one of the ester-linked fatty acids (17). Assum-
ing that this defect in 0-acylation of lipoprotein is caused
by the substitution of COOH-subterminal arginine by
cysteine, the transacylation of monoacylglyceryl-prolipo-
protein must also be a post-translational event. In view of
the small size of Braun's lipoprotein, it is probably not
surprising that some or all of its modification and process-
ing reactions take place post translationally.
The demonstration that B. licheniformis penicillinase is
a glyceride-lipoprotein indicates that lipoproteins contain-
ing glyceride-cysteine at the NH2-termini may be ubiqui-
tous in prokaryotic cells. The localization of this hydro-
phobic moiety at the NH2-termini of membrane-bound
lipoproteins offers a simple way for the anchorage of
::::. ::: :::-::::: -1: *:: ..
-.. ......... . .. .- ...
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FIGURE 10 Schematic representation of the molecular organization of
lipoproteins in the cell envelope of gram-negative bacteria. LPS: lipopoly-
saccharide; FLP free-form Braun's lipoprotein; BLP: bound-form
Brauns hpoprotein; NLP new lipoprotein(s); OM: outer membrane; IM:
inner membrane.
otherwise hydrophilic polypeptides onto either side of the
biological membrane (Fig. 10).
The function of Braun's lipoprotein has been a mystery.
An E. coli mutant deleted for Ipp gene shows very little
change in phenotype (30). On the other hand, the primary
structures of lipoprotein are extremely well conserved
except for the signal sequence and the COOH-terminal
sequence of lipoprotein, which is involved in covalent
linkage to the peptidoglycan (31, 33). This highly
conserved primary structure of lipoprotein and the
extremely efficient expression of lipoprotein gene suggest
there must be an important function of this protein. It is
most likely that one major function of lipoprotein is
mediated through its murein-bound form, especially in
conjunction with other outer membrane proteins such as
OmpA protein (7, 34). A physiological function of the
free-form lipoprotein beyond its role as a precursor to the
murein-bound form remains obscure. The recent discovery
of minor lipoproteins with apparently similar lipid moieties
attached to different inner and outer membrane proteins
raises an intriguing question as to the functions of these
lipoproteins and the role of the covalent lipid in the
functioning of these lipoproteins. Regardless of what the
physiological function of Braun's lipoprotein may be, it is
conceivable that the functions of Braun's lipoprotein and
the new lipoproteins may not be intimately dependent on
the lipid moieties at their NH2-termini. Rather, these
lipoproteins may have diverse functions, structural or
catalytic, while they share one feature in common, i.e.,
having their NH2-termini anchored to the membrane via
modified glyceride-cysteine residues. This common feature
may have more to do with the biogenesis of these lipopro-
teins than their respective functions in the cell. This view is
strengthened by the finding that a fl-lactamase from B.
licheniformis is synthesized as a lipoprotein. The lipid
moiety at the NH2-terminus of the membrane-bound
penicillinase is not essential for its activity as a 3-
lactamase, since exo-forms of this enzyme containing no
covalent lipid are secreted into the media and are fully
active. Rather, the attachment of lipid to prepenicillinase
allows the formation of membrane-bound form of this
enzyme which is presumably anchored to the membrane
via the hydrophobic lipid moiety at the NH2-terminus.
Inasmuch as the modification enzymes are shared by
these different lipoproteins, mutants deficient in these
modification enzymes will be extremely valuable in the
elucidation of the biosynthesis and function of these lipo-
proteins.
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DISCUSSION
Session Chairman: Franklyn G. Prendergast Scribe: Jennifer L.
McKnight
PRENDERGAST: We begin with a question from a referee, John
Cronan: "Is mutant 3 -2 deficient in the synthesis of lipoproteins other
than Braun's?"
WU: No. We have been trying very hard to isolate a mutant which is
defective in the modification of lipoproteins including the new lipopro-
teins, and so far we have not yet succeeded.
ENGELMAN: If the function of the linkage of lipid is to anchor the
protein in the plasma membrane, how do you imagine the protein
traversing the periplasmic space and arriving in the outer membrane?
The most extreme case would be motion to the outer leaflet of the outer
membrane bilayer.
WU: A very good question. The problem is that although we know there
are many lipoproteins in E. coli, we don't have any information on their
topology. So we actually don't know whether they go into the outer leaflet
of the membrane or the inner leaflet. Braun's lipoprotein is the only one
which is presumed to be facing inward because the C-terminal end of this
protein is attached to the peptidoglycan. So it is reasonable to assume
that the lipid is anchored in the inner leaflet of the outer membrane.
ENGELMAN: But if it is modified on the plasma membrane, how does
it get across?
WU: That is a question that many of us would like to answer. That is,
how does a protein go from the inner membrane to the outer membrane?
The mature lipoprotein is translocated from the cytoplasmic membrane
to the outer membrane extremely rapidly, with a transit time of seconds.
If the lipid is not present but the leader sequence remains intact, for
example a mutant prolipoprotein which cannot be modified, this lipid-
deficient prolipoprotein can get to the outer membrane without much
difficulty, and the transit time is also very rapid. In the globomycin
treated cell, the prolipoprotein which contains lipid can not get out, and
we don't know why. Presumably, the lipid moiety plus the hydrophobic
leader sequence keep this protein from getting to the outer membrane. As
far as the translocation of proteins to the outer membrane is concerned,
several models have been proposed which involve Bayer's zone of adhe-
sion (Osborn et al. 1980. Annu. Rev. Microbiol. 34:369 -422).
PRENDERGAST: Do you know anything about the protease responsi-
ble for the processing?
WU: All we know is that there is a leader peptidase for the bacterio-
phage M-13 procoat protein which has been purified by Wickner as a
membrane bound enzyme. The leader peptidase for the prolipoprotein
has been solubilized. We know it is a membrane bound enzyme, but there
is no purification data. It is an endopeptidase which cleaves at the correct
site.
PRENDERGAST: Have you any synthetic substrates for this enzyme?
WU: No. The substrate we have been using is the precursor protein.
STEVEN: There have been models around for a number of years which
suggest that the lipoprotein forms an oligomer. There was Inouye's
coiled-coil model (M. Inouye. 1974. Proc. Natl. Acad. Sci. U.S.A.
71:2396 -2400), in which lipoproteins were still being thought of as a
potential porin. More recently, McLachlan (A. D. McLachlan. 1978. J.
Mol. Biol. 121:493 -506) has formulated a model proposing a double-
a-helical, coiled coil. Have there been any developments, experimental or
otherwise, on the possible oligomeric state of lipoprotein in the
membrane?
WU: Both schemes (Inouye and McLachlan) are based on model
building. Inouye has built a model trying to use lipoprotein as a
hydrophilic pore across the outer membrane. The porin has now been
identified as being another protein.
There are no good physicochemical data to tell us how far the
lipoprotein is embedded in the outer membrane, so in that sense we have
no information about either the oligomeric structure, or even how deep it
goes into the outer membrane.
TROY: Implicit in Fig. 9 is that the peptidase acts by "dipping" into the
bilayer. Is there evidence as to where that peptide cleavage occurs relative
to the face of the bilayer?
WU: Modification and processing are assumed to take place at the
outside of the inner membrane, but there is no direct evidence to support
this. It is part of the inner membrane.
TROY: So Fig. 9 then, where it shows the peptidase penetrating into the
bilayer is speculative?
WU: It is hypothetical.
TROY: The model should be modified then to put the cleavage site
outside of the phospholipid bilayer.
WU: We are postulating that the lipoprotein-specific signal peptidase
may require modified protein as a substrate.
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